Korean J Ophthalmol.  2017 Aug;31(4):370-371. 10.3341/kjo.2017.0011.

Second Primary Rhabdomyosarcoma in Nonhereditary Unilateral Retinoblastoma Not Treated with Radiotherapy

Affiliations
  • 1Department of Ophthalmology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
  • 2Department of Ophthalmology, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea. hokyung214@gmail.com
  • 3Department of Ophthalmology, Kangwon National University Hospital, Kangwon National University Graduate School of Medicine, Chuncheon, Korea.
  • 4Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea.
  • 5Department of Ophthalmology, Seoul National University Bundang Hospital, Seongnam, Korea.

Abstract

No abstract available.


MeSH Terms

Radiotherapy*
Retinoblastoma*
Rhabdomyosarcoma*

Reference

1. Albert DM, Miller JW, Azar DT, Blodi BA. Albert & Jakobiec's principles and practice of ophthalmology. Philadelphia: Elsevier;2008. p. 367.
2. Shields CL, Shields JA, Honavar SG, Demirci H. Clinical spectrum of primary ophthalmic rhabdomyosarcoma. Ophthalmology. 2001; 108:2284–2292. PMID: 11733272.
Article
3. Turaka K, Shields CL, Meadows AT, Leahey A. Second malignant neoplasms following chemoreduction with carboplatin, etoposide, and vincristine in 245 patients with intraocular retinoblastoma. Pediatr Blood Cancer. 2012; 59:121–125. PMID: 21826785.
Article
4. Araki Y, Matsuyama Y, Kobayashi Y, et al. Secondary neoplasms after retinoblastoma treatment: retrospective cohort study of 754 patients in Japan. Jpn J Clin Oncol. 2011; 41:373–379. PMID: 21051531.
Article
5. Suttie CF, Hong A, Stalley P, et al. Does chemotherapy shorten the latency interval of radiation-induced sarcomas? Clin Oncol (R Coll Radiol). 2012; 24:77–79. PMID: 22015059.
Article
Full Text Links
  • KJO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr